PCSK9 and Hypercholesterolemia: Structure-function analyses of PCSK9 confirmed that the protective variants were indeed loss-of-function variants with defective synthesis, trafficking, or secretion, while variants associated with hypercholesterolemia featured gain-of-function mechanisms that increased interactions between PCSK9 and LDL receptors (7, 12).